Baccharis concava
Baccharis concava · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Baccharis concava is a botanical species that has garnered significant scientific interest due to its potent antimicrobial activities. Research focusing on its hydroalcoholic extract has revealed a rich profile of bioactive compounds, including flavonoids, steroids, terpenoids, and dicaffeoylquinic acid. These chemical constituents contribute to the plant's ability to combat various challenging pathogens. Specifically, the extract demonstrates effectiveness against Gram-positive bacteria, such as Staphylococcus aureus, as well as fungal threats like Candida albicans and Cryptococcus neoformans. Consequently, this plant represents a promising natural source for developing new therapeutic agents against microbial infections.
- Synonyms
- Baccharis Macraei Var. Intermedia · Conyza Concava · 1 more
- Common names
- Not available
- Family
- Asteraceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Baccharis concava is a resilient plant species known by several distinct regional names. In certain areas, it is commonly referred to as Vautro or Wawtro. It is also frequently identified by the name gaultro in local contexts. Within Chile, the plant is specifically known by the common name guauchu. These diverse naming conventions reflect the varied linguistic landscapes where the species thrives.
Sources: Catalogue of Life (COL)
Synonyms
Baccharis concava is a botanical species that has been classified under several different scientific names throughout history. Taxonomists have frequently referred to this plant as Baccharis macraei var. intermedia in various studies. Additionally, the species is recognized by the synonym Conyza concava within certain botanical records. It has also been documented under the name Molina concava, reflecting the evolving nature of plant nomenclature. Understanding these shifting relationships is essential for accurate identification and scientific consistency.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Baccharis concava is a fascinating species that belongs to the kingdom Plantae. Within this vast botanical realm, it is classified under the class Equisetopsida. The plant further belongs to the order Asterales, showcasing its evolutionary connections. It is a member of the diverse family Asteraceae, which is known for its distinctive floral structures. Finally, this species is categorized under the specific genus Baccharis.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asterales |
| Family | Asteraceae |
| Genus | Baccharis |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Baccharis concava is a distinctive plant species primarily found throughout the diverse landscapes of Southern America. Its geographic reach extends significantly into the southern reaches of the South American continent, where it thrives in specific ecological niches. Within this vast range, the species maintains a particularly notable presence across the central regions of Chile. This distribution highlights the plant's ability to adapt to the unique environmental conditions found in these southern latitudes. Understanding these regional patterns is essential for documenting the botanical diversity of the area.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Baccharis concava is a hardy shrub that maintains a distinct, bushy growth form. As a self-supporting species, it stands firmly on its own without the need for external structural support.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Baccharis concava is a native shrub from the central Chilean coast that has long been utilized by indigenous populations for its medicinal properties. Recent phytochemical investigations have revealed that its hydroalcoholic extracts contain a diverse array of compounds, including alkaloids, steroids, and flavonoids. Notably, the plant demonstrates significant antimicrobial activity against several Gram-positive bacteria and pathogenic yeasts such as Candida albicans. This biological effectiveness is largely attributed to specific metabolites like caffeoylquinic acid and quercetin, which may also assist in wound healing. Ultimately, these findings suggest that Baccharis concava could serve as a valuable foundation for developing targeted therapies to combat specific infections.
Compounds
Baccharis concava is a native shrub from the central Chilean coast that possesses a diverse array of bioactive phytochemicals. Detailed characterization of its hydroalcoholic extract reveals the presence of essential compounds such as steroids and terpenoids. Furthermore, the plant is rich in flavonoids, which contribute to its significant medicinal potential. Specific analysis further identifies key phenolic acid derivatives, including caffeoylquinic acid and dicaffeoylquinic acid. These various metabolites are believed to drive the plant's strong antimicrobial activity against certain bacteria and pathogenic yeasts.
Conditions
Baccharis concava exhibits significant antimicrobial properties that allow it to treat the pathogenic yeasts Candida albicans and Cryptococcus neoformans. The plant's extracts also demonstrate an important effect against Gram-positive bacteria, providing a means to treat infections caused by these microorganisms. Specifically, the study highlights its ability to treat Staphylococcus aureus through highly active molecular fractions. These therapeutic capabilities are likely driven by metabolites such as phenolic acids and flavonoids found within the plant. Consequently, Baccharis concava holds potential for developing new therapies to combat these specific bacterial and fungal threats.
Preparations
Baccharis concava is prepared as a hydroalcoholic extract utilizing its leaves and small branches. This specific preparation allows for the qualitative phytochemical characterization of various compounds like alkaloids, steroids, and flavonoids. Once the hydroalcoholic extract is obtained, it can be further fractionated through a Sephadex LH-20/methanol-ethyl acetate column. The resulting fractions are then assessed to identify which specific components provide the most significant antimicrobial activity. Ultimately, the preparation of this hydroalcoholic extract serves as the foundation for discovering molecules that combat pathogenic yeasts and Gram-positive bacteria.